The nation of Zimbabwe has rejected a major American health deal valued at $367m (272 million pounds) over five years because of Washington's demand for confidential biological samples.
This rejection became public after a official document from December was disclosed, revealing that Head of State Emmerson Mnangagwa believed the deal was "lopsided".
A government spokesman has since stated that the United States was requesting health data for research and profit while was unwilling to guarantee the benefits from any future vaccines.
"We will now turn to the difficult and regrettable process of scaling back our health aid in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy indicated the US had provided over $1.9bn for health programmes to Zimbabwe during the past twenty years.
A medical body in Zimbabwe has called for further talks to reach a deal acceptable to all parties so the country's vital HIV treatment initiative can continue.
Wider Implications
This rejection follows a comparable situation in neighbouring Kenya, where a high court halted a related health funding agreement following legal challenges were filed about the safety of citizens' health data.
After returning to the presidency recently, US President Donald Trump has drastically cut foreign aid and shut down the US Agency for International Development (USAID).
USAID had administered aid for the American government, but Trump argued its spending was "wasteful" and his administration was pursuing direct bilateral deals to enhance openness and accountability.
Based on reports, 16 nations in Africa have so far signed similar agreements, constituting more than $18.3bn in committed funds.
Details of the Rejected Deal
The funds for Zimbabwe would have supported "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"It is our view this cooperation would have delivered significant benefits for the people of Zimbabwe, especially the 1.2 million currently receiving HIV treatment through US-supported programmes," the Ambassador added.
However, government spokesperson Nick Mangwana said the arrangement was "unfair".
"Zimbabwe was being asked to surrender its genetic material and health information indefinitely, without any equivalent promise of access to any scientific breakthroughs – like vaccines, diagnostics, or treatments – that could be developed from that shared data," he stated.
"Effectively, our country would provide the basic resources for scientific discovery with no certainty that the resulting innovations would be accessible to our people should a future health crisis arise."
Sovereignty and Global Health
He also noted that the US's withdrawal from the World Health Organization (WHO) and its pursuit of bilateral health agreements were undermining structures already set up through the international health agency.
The spokesperson cited its Pathogen Access and Benefit Sharing framework created to deal with future pandemics.
"This framework is intended to guarantee that when a country contributes its information, the resulting advantages – such as medicines and cures – are shared equitably, not commercialised solely by those with the resources to develop them."
The government's concerns regarding the US deal "must not be interpreted as opposition to America," Mangwana stressed.
"We welcome continued discussions with our American counterparts on how subsequent co-operation could be arranged in a way that respects the independence and dignity of each country."
Health Experts Response
Medical experts expressed it recognised the government's concerns, but recommended that talks must proceed since much of the nation's HIV programmes were funded by foreign aid.
"In cases where specific concerns arise, such as those involving information security or implementation frameworks, these can frequently be resolved via technical clarification and negotiated safeguards," the group commented.
The situation highlights the complex challenges between receiving crucial international aid and protecting a country's data in an ever more interconnected world.